Become an expert in R — Interactive courses, Cheat Sheets, certificates and more!
Get Started for Free

EBMT-platelet-recovery-data

Data from the European Society for Blood and Marrow Transplantation (EBMT)


Description

A data frame of 2204 patients transplanted at the EBMT between 1995 and 1998. These data were used in Section 4 of the tutorial on competing risks and multi-state models (Putter, Fiocco & Geskus, 2007). The included variables are

id

Patient identification number

prtime

Time in days from transplantation to platelet recovery or last follow-up

prstat

Platelet recovery status; 1 = platelet recovery, 0 = censored

rfstime

Time in days from transplantation to relapse or death or last follow-up (relapse-free survival time)

rfsstat

Relapse-free survival status; 1 = relapsed or dead, 0 = censored

dissub

Disease subclassification; factor with levels "AML", "ALL", "CML"

age

Patient age at transplant; factor with levels "<=20", "20-40", ">40"

drmatch

Donor-recipient gender match; factor with levels "No gender mismatch", "Gender mismatch"

tcd

T-cell depletion; factor with levels "No TCD", "TCD"

Format

A data frame, see data.frame.

Source

We acknowledge the European Society for Blood and Marrow Transplantation (EBMT) for making available these data. Disclaimer: these data were simplified for the purpose of illustration of the analysis of competing risks and multi-state models and do not reflect any real life situation. No clinical conclusions should be drawn from these data.

References

Putter H, Fiocco M, Geskus RB (2007). Tutorial in biostatistics: Competing risks and multi-state models. Statistics in Medicine 26, 2389–2430.


mstate

Data Preparation, Estimation and Prediction in Multi-State Models

v0.3.1
GPL (>= 2)
Authors
Hein Putter [aut, cre], Liesbeth C. de Wreede [aut], Marta Fiocco [aut], Ronald B. Geskus [ctb], Edouard F. Bonneville [ctb], Damjan Manevski [ctb]
Initial release
2020-12-17

We don't support your browser anymore

Please choose more modern alternatives, such as Google Chrome or Mozilla Firefox.